eprintid: 1625
rev_number: 9
eprint_status: archive
userid: 6
dir: disk0/00/00/16/25
datestamp: 2013-07-01 09:02:18
lastmod: 2013-07-01 09:02:18
status_changed: 2013-07-01 09:02:18
type: monograph
metadata_visibility: show
creators_name: Magazzini, Laura
creators_name: Pammolli, Fabio
creators_name: Riccaboni, Massimo
creators_id: 
creators_id: f.pammolli@imtlucca.it
creators_id: massimo.riccaboni@imtlucca.it
title: R&D, Within and Between Patent Competition in the Pharmaceutical Industry
ispublished: pub
subjects: HB
subjects: RS
divisions: EIC
full_text_status: public
monograph_type: imt_eic_working_paper
keywords: Patent value, innovation, R&D competition, pharmaceutical industry. -   
JEL Classification: D23; D83; O34; O31; L13.
abstract: We analyse the consequences of the increasing complexity of R&D on within- and between-patent competition in the pharmaceutical industry. The intensity of competition
is measured by jointly considering the timing from market launch to patent expiry, the strength of between-patent competition as well as competition introduced by generic
producers. A simple model is proposed that predicts the shrinking of product lifetimes in the presence of correlated parallel R&D projects and market portfolios. The model is tested using data on pharmaceutical products sold in Europe and in the US. Based on our model we are able to estimate the impact of R&D complexity and relatedness
among R&D portfolios on the value of innovative drugs.
date: 2013-07
date_type: published
number: 3
pages: 41
institution: IMT Institute for Advanced Studies Lucca
issn: 2279-6894
citation:   Magazzini, Laura and Pammolli, Fabio and Riccaboni, Massimo  R&D, Within and Between Patent Competition in the Pharmaceutical Industry.  EIC working paper series  #3/2013     ISSN 2279-6894.      
document_url: http://eprints.imtlucca.it/1625/1/EIC_WP_3_2013.pdf